Two stocks I am never selling: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Amazon.com, Inc. (NASDAQ:AMZN)

0

Atlas Brown Inc. increased its holdings in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 6.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,025 shares of the e-commerce giant’s stock after acquiring an additional 61 shares during the quarter. Amazon.com comprises 1.6% of Atlas Brown Inc.’s portfolio, making the stock its 15th biggest holding. Atlas Brown Inc.’s holdings in Amazon.com were worth $1,998,000 as of its most recent SEC filing.

Amazon.com (NASDAQ:AMZN) stock closed at $2,375.00 on Friday. The company has a current ratio of 1.10, a quick ratio of 0.86 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $1,198.93 billion, a PE ratio of 104.66, a P/E/G ratio of 3.70 and a beta of 1.25. Amazon.com, Inc. has a 12 month low of $1,626.03 and a 12 month high of $2,461.00. The stock has a 50-day moving average price of $1,932.16 and a two-hundred day moving average price of $1,867.44.

Patten & Patten Inc. TN acquired a new stake in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 465 shares of the biopharmaceutical company’s stock, valued at approximately $227,000.

Shares of REGN closed at $568.79 on Friday. Regeneron Pharmaceuticals Inc has a 1 year low of $271.37 and a 1 year high of $572.50. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.67 and a quick ratio of 2.99. The company has a market capitalization of $62.58 billion, a price-to-earnings ratio of 30.81, a price-to-earnings-growth ratio of 1.06 and a beta of 0.52. The business has a 50-day moving average of $477.33 and a 200-day moving average of $383.11.